Seed is a microbiome-focused health company developing clinically studied probiotics to improve human and planetary health. Based in Los Angeles, the company emphasizes research-backed formulations like the DS-01 Daily Synbiotic, combining probiotics and prebiotics for systemic benefits. Seed collaborates with scientists and partners worldwide to address gastrointestinal, dermatological, oral, pediatric, and nutritional health through its daily synbiotic products.
No recent deals for this company.